in 45 patients considered to be at higher risk for malIgnant arrhythmia for 24 to 48 hours.
The inclusion criteria was acute coronary syndrome, cardiogemc shock and previous episode of sudden death or malignant ventricular arrhythmia. The exclusion cnteria was the use of pacemaker or an implantable cardioverier defibrillator and an R-wave amplitude less than 0.7mV peak to peak at themonitor. Results: We recorded 17 episodes of VTNF in 3 patients. The median time between the beginning of the arrhythmia and the first defibrillation was 33.37 s (range 21 to 65 s). The sensibility and specificity were 100%. The success of the defibrillation was 94.11% (16/ 17) for the first shock and 100% (l/l) for the second shock. There was no adverse event during the study penod and no episodes of inappropriate therapy delivery (the detection was accurate in all episodes sensitivity 100%). Conclusion: AECD was safe and effective. It presents the possibility of providing consistently rapid identification and response to ventricular malignant arrhyihmla.
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The Potential Impact of a Fully Automated External Cardioverter Defibrillator in Centrally Monitored Hospital Units
Hew
Cusnir, Rohit Tongia. David Kavesteen, Karthik P. Sheka, Frederick Cassera.
Hannah Scherer, Louise Valeno, Gerald Hollander, Maimonides Medical Center. Brooklyn, NY Background: Sudden Cardiac Arrest (SCA) survival decreases by 10% for each minute of delay in cardioversion, wth survival rates of 96% noted when defibrillation is achieved within 30 seconds of collapse. This has led to increasing use of semi-automated external defibrillators in many out-of-hospital settings. Recently, a fully automated external cardioverter-defibrillator (AECD) was approved by the FDA for in-hospital use. The AECD can be programmed to automatically defibrillate a life threatening ventricular arrhythmia. The purpose of this study was to assess the potential impact of in-hospital AECDs on the critical time to defibrillation in monitored hospital units.
Methods:
Mock codes (n=l6) were conducted using simulated ventricular fibrillation in various monitored units. Observers were stationed to record the time staff responded to the arrhythmia, and the time to shock. These times were compared to an AECD protocol that automatically defibrillates at an average of 36.3 seconds from onset of arrhythmia (ll=l8).
Results:
Staff vs AECD response time to arrhythmia (seconds) was 76.3 f 113.7 (Cl 19.6 132.6) vs 7.6 f 0.6 (Cl 7.3 7.9). Staff vs AECD time to shock was 169.2 * 103.1 (Cl 117.9 -220.4) vs 36.3 * 0.7'(CI 37.9 -36.6). p values are < 0.0001 for differences between the groups. The use of GP Ilb/llla Inhibitors among patients with ACS undergoing inhospital CABG I?. associated with a benefit that persists at 6 months.
